跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSUVASTATINA/EZETIMIBA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROSUVASTATINA/EZETIMIBA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ROSUVASTATINA/EZETIMIBA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 8, 2023
Approval ID
376c59d115b480e8
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
376c59d115b480e8
Drug Cima Aemps Name
ROSUVASTATINA/EZETIMIBA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
88823
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2023-05-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
ROSUVASTATINA CALCICA
10,4 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 8, 2023
Approval ID
376c59d115b480e8
Type
Standard
Back to CIMA-AEMPS Approvals